WO2024018420 - CONTINUOUS DELIVERY SYSTEMS COMPRISING A CANNABINOID AND MEDICINAL USES THEREOF
National phase entry:
Publication Number
WO/2024/018420
Publication Date
25.01.2024
International Application No.
PCT/IB2023/057416
International Filing Date
20.07.2023
Title **
[English]
CONTINUOUS DELIVERY SYSTEMS COMPRISING A CANNABINOID AND MEDICINAL USES THEREOF
[French]
SYSTÈMES D'ADMINISTRATION CONTINUE COMPRENANT UN CANNABINOÏDE ET LEURS UTILISATIONS MÉDICINALES
Applicants **
PIKE THERAPEUTICS INC.
Inventors
MILES, Brad
PLAKOGIANNIS, Fotios
Priority Data
63/391,004
21.07.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CIPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4576 | |
| EPO | Filing, Examination, Granting | 67777 | |
| Japan | Filing, Examination, Granting | 4129 | |
| South Korea | Filing, Examination, Granting | 6269 | |
| USA | Filing, Examination, Granting | 16790 |
Total:
99,541
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Compositions comprising 0.1-50 % delta-9-tetrahydrocannabinol and/or cannabidiol in forms suitable for continuous delivery and use thereof in the treatment of a variety of diseases and pathological disorders are disclosed. In preferred embodiments, the compositions are in a form suitable for delivery via a portable infusion pump or transdermal patch. The disorders to be treated include pain, cancer, seizure disorders, and Parkinson's disease. Depending on the disorder to be treated, the compositions may optionally further comprise additional active agents such as dopaminergic agents.[French]
L'invention concerne des compositions comprenant de 0,1 à 50 % de delta-9-tétrahydrocannabinol et/ou de cannabidiol dans des formes appropriées pour une administration continue et leur utilisation dans le traitement de diverses maladies et de divers troubles pathologiques. Dans des modes de réalisation préférés, les compositions se présentent sous une forme appropriée pour une administration par l'intermédiaire d'une pompe à perfusion portable ou d'un timbre transdermique. Les troubles à traiter comprennent la douleur, le cancer, les troubles épileptiques et la maladie de Parkinson. En fonction du trouble à traiter, les compositions peuvent éventuellement également comprendre des agents actifs supplémentaires tels que des agents dopaminergiques.